» Articles » PMID: 17145848

Preparing the "soil": the Premetastatic Niche

Overview
Journal Cancer Res
Specialty Oncology
Date 2006 Dec 6
PMID 17145848
Citations 270
Authors
Affiliations
Soon will be listed here.
Abstract

Current focus on cancer metastasis has centered on the intrinsic factors regulating the cell autonomous homing of the tumor cells to the metastatic site. Specific up-regulation of fibronectin and clustering of bone marrow-derived cellular infiltrates coexpressing matrix metalloproteinases in distant tissue sites before tumor cell arrival are proving to be indispensable for the initial stages of metastasis. These bone marrow-derived hematopoietic progenitors that express vascular endothelial growth factor receptor 1 mobilize in response to the unique array of growth factors produced by the primary tumor. Their arrival in distant sites represents early changes in the local microenvironment, termed the "premetastatic niche," which dictate the pattern of metastatic spread. Focus on the early cellular and molecular events in cancer dissemination and selectivity will likely lead to new approaches to detect and prevent metastasis at its earliest inception.

Citing Articles

Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives.

Minges P, Eder M, Eder A Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005958 PMC: 11858487. DOI: 10.3390/ph18020143.


A Multicellular Mechanochemical Model to Investigate Tumor Microenvironment Remodeling and Pre-Metastatic Niche Formation.

Hirway S, Nairon K, Skardal A, Weinberg S Cell Mol Bioeng. 2025; 17(6):573-596.

PMID: 39926379 PMC: 11799507. DOI: 10.1007/s12195-024-00831-0.


A Personalized Approach for Oligometastatic Prostate Cancer: Current Understanding and Future Directions.

Alerasool P, Zhou S, Miller E, Anker J, Tsao B, Kyprianou N Cancers (Basel). 2025; 17(1).

PMID: 39796774 PMC: 11720581. DOI: 10.3390/cancers17010147.


The Role of eHsp90 in Extracellular Matrix Remodeling, Tumor Invasiveness, and Metastasis.

Singh P, Jay D Cancers (Basel). 2024; 16(22).

PMID: 39594828 PMC: 11592750. DOI: 10.3390/cancers16223873.


Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials.

Mayasin Y, Osinnikova M, Kharisova C, Kitaeva K, Filin I, Gorodilova A Cells. 2024; 13(22).

PMID: 39594665 PMC: 11592585. DOI: 10.3390/cells13221917.


References
1.
Welch D, Steeg P, Rinker-Schaeffer C . Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res. 2001; 2(6):408-16. PMC: 138663. DOI: 10.1186/bcr87. View

2.
Lin E, Nguyen A, Russell R, Pollard J . Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med. 2001; 193(6):727-40. PMC: 2193412. DOI: 10.1084/jem.193.6.727. View

3.
Masood R, Cai J, Zheng T, Smith D, Hinton D, Gill P . Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood. 2001; 98(6):1904-13. DOI: 10.1182/blood.v98.6.1904. View

4.
Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L . Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 2001; 7(11):1194-201. DOI: 10.1038/nm1101-1194. View

5.
Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett N . Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002; 109(5):625-37. PMC: 2826110. DOI: 10.1016/s0092-8674(02)00754-7. View